As of September 30, 2026, the Company determined that the sale of Omnicare’s assets is probable of occurring in the fourth quarter of 2026, and accordingly recorded an estimated contingent guarantee liability of $193 million during the three and nine months ended September 30, 2026. The liability reflects the Company’s estimated obligation to ensure that the DOJ receives a minimum of $440 million from Omnicare and CVS Health Corporation in accordance with the agreements.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.